Zealand Pharma major shareholder announcement: Polar Capital
2022年10月12日 - 12:05AM
Company announcement – No. 47 / 2022
Zealand Pharma major shareholder announcement: Polar
Capital
Copenhagen, Denmark and Boston, MA, 11 October 2022 –
Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50
78), a Copenhagen-based biotechnology company focused on the
discovery and development of innovative peptide-based medicines,
today announces the receipt on 11 October 2022 of notification
pursuant to Section 38 of the Danish Capital Markets Act from the
following major shareholders:
As of 10 October 2022, Polar Capital LLP holds nominally
5,930,317 shares (each share carrying one vote) in Zealand Pharma
A/S, corresponding to 11.51% of the total share capital and total
voting rights in Zealand Pharma A/S.
Please see further details in the attached notification
form.
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology
company focused on the discovery and development of peptide-based
medicines. More than 10 drug candidates invented by Zealand have
advanced into clinical development, of which two have reached the
market and three candidates are in late-stage development. In
addition, license collaborations with Boehringer Ingelheim and
AstraZeneca create opportunities for more patients to potentially
benefit from Zealand-invented peptide investigational agents
currently in development.
Zealand was founded in 1998 and is headquartered in Copenhagen,
Denmark, with a presence in the U.S. that includes Boston. For more
information about Zealand’s business and activities, please
visit www.zealandpharma.com.
Contact:
Anna Krassowska, PhD Vice President, Investor Relations &
Corporate Communications Zealand Pharma Email:
ank@zealandpharma.com David Rosen (U.S. Media) Argot
Partners Email:
media@zealandpharma.com
|
- Zealand Pharma - Disclosure Form - 11.10.2022
Zealand Pharma AS (NASDAQ:ZEAL)
過去 株価チャート
から 5 2024 まで 6 2024
Zealand Pharma AS (NASDAQ:ZEAL)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Zealand Pharma AS (ナスダック市場): 0 recent articles
その他のニュース記事